Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 72.55 Million | USD 97.17 Million | 3.3% | 2023 |
The global Bovine Ephemeral Fever Vaccines Market size was valued at USD 72.55 Million in 2023 and is predicted to reach USD 97.17 Million by the end of 2032. The market is expected to grow with a CAGR of 3.3% during the forecast period. The report analyzes the global Bovine Ephemeral Fever Vaccines Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Bovine Ephemeral Fever Vaccines industry.
The study includes drivers and restraints for the bovine ephemeral fever vaccines market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the bovine ephemeral fever vaccines market on a global level.
In Global bovine ephemeral fever vaccines market Report, Worldwide demand for bovine ephemeral fever vaccines is growing at a rapid pace. Global demand for bovine ephemeral fever vaccines is expected to be driven by increasing demand from pharmaceutical companies, large number of companies providing healthcare services and vaccines, a large number of biopharmaceutical companies producing vaccines, and a high incidence of bovine ephemeral fever (BEF) among cattle and buffaloes. The increase in R&D in the field of vaccines is expected to be the major factor attributing to the growth of bovine ephemeral fever vaccines market.
However, the practical difficulties in the administration of the vaccine and the lack of trained veterinarian professionals may act as a restraint for bovine ephemeral fever vaccines market growth. Emerging countries are expected to bring new growth avenues for bovine ephemeral fever vaccines manufacturers.
The market is segmented into type, application, end user, and region. Among the type segment, there are live vaccines, killed vaccines, and other types. Applications include vaccines administered among cattle and water buffaloes. A large number of cattle and water buffaloes in the sub-tropical regions of Asia, Australia, Africa, and the Middle-East are affected by this disease. Live-attenuated vaccines held the largest market share in 2018. This has been observed by testing and demonstrating results in various affected cattle.
Report Attributes | Report Details |
---|---|
Report Name | Bovine Ephemeral Fever Vaccines Market |
Market Size in 2023 | USD 72.55 Million |
Market Forecast in 2032 | USD 97.17 Million |
Growth Rate | CAGR of 3.3% |
Number of Pages | 203 |
Key Companies Covered | Zoetis Inc, Onderstepoort Biological Products SOC Ltd, Green Cross Veterinary Products Co Ltd, Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co Ltd |
Segments Covered | By Type, By Application, By End-User and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The duration of immunity conferred by these vaccines is high. medical device companies, pharmaceutical industries, and animal hospitals are the various end users in this market. Animal hospitals are the major end user segment which dominated the market in terms of revenue in 2023 owing to a large number of diseased cattle that are treated and the intensive care that is provided in such establishments.
North America dominated global bovine ephemeral fever vaccines market. North America region is projected to lead the market over the forecast period with progress mostly focused in the U.S. market. There are a large number of companies which are heavily investing in research and development of vaccines for animal health care. There are a growing number of biopharmaceutical companies in the market which are developing vaccines for animal care and prevention of diseases. Europe was second largest in bovine ephemeral fever vaccines market in 2023 globally. The spike of R&D in the field of animal and human health care, large number of companies manufacturing vaccines and advanced technologies is the major factor driving the demand for bovine ephemeral fever vaccines in Europe. Asia Pacific, the Middle East and Africa are having high prevalence of BEFV infection.
This is due to the sub-tropical temperatures which result in anorexia, lameness, ruminal stasis, fever and a reduction in production of milk. However, to tackle this onslaught of vector-borne diseases, there is regular vaccination carried out, resulting in a growth of CAGR over the forecast period. There is also improved awareness among people to take care of the animals and growing demand for biotechnological companies to produce related vaccines.
Some of the key players in bovine ephemeral fever vaccines market include
Global Bovine Ephemeral Fever Vaccines Market: Type Segments
Global Bovine Ephemeral Fever Vaccines Market: Application Segments
Global Bovine Ephemeral Fever Vaccines Market: End-User Segments
Global Bovine Ephemeral Fever Vaccines Market: Regional Segments
FrequentlyAsked Questions
The study includes drivers and restraints for the bovine ephemeral fever vaccines market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the bovine ephemeral fever vaccines market on a global level.
Global Bovine Ephemeral Fever Vaccines market size earned around $72.55 Mn in 2023 and is expected to reach $97.17 Mn by 2032, with a CAGR of 3.3%.
North America dominated global bovine ephemeral fever vaccines market. North America region is projected to lead the market over the forecast period with progress mostly focused in the U.S. market. There are a large number of companies which are heavily investing in research and development of vaccines for animal health care. There are a growing number of biopharmaceutical companies in the market which are developing vaccines for animal care and prevention of diseases. Europe was second largest in bovine ephemeral fever vaccines market in 2018 globally. The spike of R&D in the field of animal and human health care, large number of companies manufacturing vaccines and advanced technologies is the major factor driving the demand for bovine ephemeral fever vaccines in Europe. Asia Pacific, the Middle East and Africa are having high prevalence of BEFV infection.
Some of the key players in bovine ephemeral fever vaccines market include Zoetis Inc., Onderstepoort Biological Products SOC Ltd., Green Cross Veterinary Products Co. Ltd., Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co. Ltd. among others.
Global Bovine Ephemeral Fever Vaccines market size earned around $72.55 Mn in 2023 and is expected to reach $97.17 Mn by 2032, with a CAGR of 3.3%.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed